B.Riley Financial Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $20

Moomoo News14:31 ET · Ratings

B.Riley Financial Keeps Their Buy Rating on Altimmune (ALT)

TipRanks13:41 ET · Ratings

Altimmune Call Volume Above Normal and Directionally Bullish

TipRanksDec 20 10:25 ET

Express News | Shares of Viking Therapeutics up 9.3%, Structure Therapeutics up 3.4%, Altimmune up 1.7% Premarket

ReutersDec 20 06:04 ET

Express News | Weight Loss Drug Developers Rise Intraday Trading After Novo Nordisk's Obesity Drug Cagrisema Achieves Lower Weight Loss Than Expected

ReutersDec 20 06:03 ET

Hims & Hers Shares Tumble as FDA Resolves Obesity Drug Shortage

InvestingDec 19 09:24 ET